Abbvie strikes deal for Botox -maker Allergan
The deal diversifies AbbVie’s revenue from Humira and will also return Allergan to the U.S., at least for tax purposes.
The deal diversifies AbbVie’s revenue from Humira and will also return Allergan to the U.S., at least for tax purposes.